Literature DB >> 17676453

Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?

L Yap1, A Kouyialis, T R K Varma.   

Abstract

Disabling tremor is common in multiple sclerosis and up to 75% of patients experience tremor at some point during their disease. The treatment of this tremor, however, remains challenging. Pharmacotherapy in general has been disappointing and stereotactic neurosurgery is becoming increasingly popular. However, the results of stereotactic treatments reported are variable and no systematic review has been performed. The aim of this study was to assess the role of thalamotomy and deep brain stimulation in the treatment of tremor in multiple sclerosis, and to compare the differences in efficacy and safety between the two techniques. We identified the relevant published studies and cases by searching the MEDLINE, EMBASS and the references lists of related articles, and performed a systematic review and assessment of the full texts of all articles selected. Initial tremor suppression was seen in 93.8% of patients who had thalamotomy and 96% in those who had deep brain stimulation. A total of 63.5% of patients had persistent tremor suppression at 12 months or more after thalamotomy. Twelve results for deep brain stimulation were not available in the reviewed literature. Functional improvement was seen only in 47.8% of those who underwent thalamotomy as opposed to 85.2% of those who had deep brain stimulation. While three of the four reported deaths were in patients who underwent thalamotomy, three of the four procedure-related haemorrhages followed DBS. Other common adverse effects like hemiparesis, dysarthria, swallowing difficulties, balance disorder, etc., was reported in both procedures. Numerous studies have attempted to assess the efficacy and safety of thalamotomy and DBS in the treatment of MS tremor, but no standardized outcome measures were used. Nonetheless, the data suggest that both thalamotomy and thalamic DBS are comparable procedures for tremor suppression and that adverse effects can occur with both procedures.

Entities:  

Mesh:

Year:  2007        PMID: 17676453     DOI: 10.1080/02688690701544002

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  11 in total

1.  Therapeutic interventions in the primary hereditary ataxias.

Authors:  Gonzalo J Revuelta; George R Wilmot
Journal:  Curr Treat Options Neurol       Date:  2010-07       Impact factor: 3.598

2.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 3.  Deep brain stimulation and tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

4.  Cerebellar Ataxia from Multiple Potential Causes: Hypothyroidism, Hashimoto's Thyroiditis, Thalamic Stimulation, and Essential Tremor.

Authors:  Natalya Shneyder; Mark K Lyons; Erika Driver-Dunckley; Virgilio Gerald H Evidente
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-03-22

5.  Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.

Authors:  Andrés Labiano-Fontcuberta; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-14

6.  Moving forward: advances in the treatment of movement disorders with deep brain stimulation.

Authors:  Terry K Schiefer; Joseph Y Matsumoto; Kendall H Lee
Journal:  Front Integr Neurosci       Date:  2011-11-09

Review 7.  Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Alastair Wilkins
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

8.  Tremor in multiple sclerosis is associated with cerebello-thalamic pathology.

Authors:  Frederique Boonstra; Grace Florescu; Andrew Evans; Chris Steward; Peter Mitchell; Patricia Desmond; Brad Moffat; Helmut Butzkueven; Scott Kolbe; Anneke van der Walt
Journal:  J Neural Transm (Vienna)       Date:  2017-11-02       Impact factor: 3.575

9.  A detailed analysis of anatomical plausibility of crossed and uncrossed streamline rendition of the dentato-rubro-thalamic tract (DRT(T)) in a commercial stereotactic planning system.

Authors:  Volker A Coenen; Bastian E Sajonz; Peter C Reinacher; Christoph P Kaller; Horst Urbach; M Reisert
Journal:  Acta Neurochir (Wien)       Date:  2021-06-28       Impact factor: 2.216

10.  Targeting thalamic tremor cells in deep brain stimulation for multiple sclerosis-induced complex tremor.

Authors:  Ersoy Kocabicak; Murat Terzi; Onur Alptekin; Yasin Temel
Journal:  Surg Neurol Int       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.